IRIS
PICHINI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.457
AS - Asia 2.103
EU - Europa 1.846
SA - Sud America 364
AF - Africa 152
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.934
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.371
SG - Singapore 813
IT - Italia 391
RU - Federazione Russa 379
VN - Vietnam 374
CN - Cina 339
BR - Brasile 283
HK - Hong Kong 263
FR - Francia 193
IE - Irlanda 154
DE - Germania 153
SE - Svezia 130
GB - Regno Unito 112
UA - Ucraina 109
IN - India 88
CI - Costa d'Avorio 69
MX - Messico 49
FI - Finlandia 48
NL - Olanda 46
JP - Giappone 30
BD - Bangladesh 27
IQ - Iraq 27
PL - Polonia 27
ZA - Sudafrica 27
CA - Canada 26
TR - Turchia 26
BE - Belgio 24
AR - Argentina 23
AT - Austria 20
EC - Ecuador 17
ES - Italia 17
MA - Marocco 15
PK - Pakistan 15
ID - Indonesia 13
CO - Colombia 12
PH - Filippine 12
TH - Thailandia 10
VE - Venezuela 10
CL - Cile 9
AU - Australia 8
EG - Egitto 8
KR - Corea 8
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
DZ - Algeria 6
IR - Iran 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
IL - Israele 5
KE - Kenya 5
LT - Lituania 5
MY - Malesia 5
NP - Nepal 5
ET - Etiopia 4
MD - Moldavia 4
RS - Serbia 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
MT - Malta 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
TW - Taiwan 3
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
CD - Congo 1
CM - Camerun 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
Totale 8.928
Salva come PNG Salva come JPEG
Città #
Ashburn 774
Singapore 554
Dallas 444
Chandler 328
San Jose 266
Hong Kong 258
Des Moines 231
Fairfield 226
Jacksonville 176
Dublin 154
Beijing 124
Seattle 114
Boardman 108
Ho Chi Minh City 108
Houston 107
Wilmington 106
Hanoi 99
Woodbridge 96
New York 85
Cambridge 82
Lauterbourg 78
The Dalles 75
Los Angeles 74
Moscow 70
Abidjan 69
Lawrence 58
Princeton 58
Rome 58
Munich 54
Council Bluffs 51
San Mateo 48
Ann Arbor 43
São Paulo 41
Turin 36
London 34
Ancona 32
Helsinki 32
Mexico City 29
Chicago 26
Buffalo 24
Hefei 24
Orem 23
Milan 22
Warsaw 22
Da Nang 21
Pune 21
San Diego 21
Tokyo 21
Denver 20
Frankfurt am Main 20
Haiphong 20
Brooklyn 17
Brussels 17
Baghdad 16
Santa Clara 16
Turku 15
Washington 14
Chennai 13
Johannesburg 12
Centro 11
Manchester 11
Phoenix 11
Shanghai 11
Toronto 11
Vienna 11
Falls Church 10
Poplar 10
Boston 9
Kilburn 9
Mohali 9
Stockholm 9
Amsterdam 8
Columbus 8
Guarulhos 8
Quito 8
Atlanta 7
Cape Town 7
Guangzhou 7
Izmir 7
Jinan 7
Messina 7
Montreal 7
Norwalk 7
Querétaro 7
Salt Lake City 7
San Francisco 7
Ahmedabad 6
Ankara 6
Boydton 6
Elk Grove Village 6
Nuremberg 6
Rio de Janeiro 6
Tashkent 6
Wuhan 6
Belo Horizonte 5
Brasília 5
Civitanova Marche 5
Hangzhou 5
Medellín 5
Rancho Palos Verdes 5
Totale 6.094
Salva come PNG Salva come JPEG
Nome #
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid 272
Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy 235
Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-hexahydrocannabinol 226
New challenges in clinical and forensic toxicology 168
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 162
Analysis of perfluoroalkyl substances (PFAS) in conventional and unconventional matrices: Clinical outcomes 158
Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study 154
Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid 153
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 151
Monitoring Prenatal Exposure to Buprenorphine and Methadone 146
THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis" 138
Toxicology and analysis of psychoactive tryptamines 138
Herbal preparations of medical cannabis: A vademecum for prescribing doctors 128
Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH 127
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 127
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid 125
Analytical procedures and blood threshold values to ascertain driving in a stae of psycho-physical impairment from drugs abuse|Procedure analitiche e valori decisionali ematici per accertare la guida in stato di alterazione psicofisica da sostanze d'abuso 125
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis 125
Determination of the synthetic cannabinoids JWH-122, JWH-210, UR-144 in oral fluid of consumers by GC-MS and quantification of parent compounds and metabolites by UHPLC-MS/MS 125
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 124
Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis 123
Commentary - Heroin purity and adulteration: An updated snapshot from the Italian Early Warning System 123
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair 118
Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans 116
Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update 116
Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 116
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations 116
A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone 115
Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease 114
Cannabidiol adverse effects and toxicity 114
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 114
Pharmacology and legal status of cannabidiol 113
European drug users at risk from illicit fentanyls mix 113
Correspondence 111
Dipyanone, a new methadone-like synthetic opioid: In vitro and in vivo human metabolism and pharmacological profiling 110
The National Early Warning System, a web-based platform to prevent the spread of New Psychoactive Substances 108
Analytical advances in clinical and forensic toxicology. Second part 106
Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use 106
Measurement uncertainty in forensic toxicology 106
Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) analysis of psychoactive drugs in oral fluid 104
Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry 101
Comment on "direct Monitoring of Exogenous γ-Hydroxybutyric Acid in Body Fluids by NMR Spectroscopy": Several Issues to Consider When Quantifying γ-Hydroxybutyric Acid in Biological Matrixes 100
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 98
Advances and future developments in forensic toxicology: From standard practices to new psychoactive substances 97
Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: A pilot study 96
Evaluation of Short-Term Stability of Different Nitazenes Psychoactive Opioids in Dried Blood Spots by Liquid Chromatography-High-Resolution Mass Spectrometry 95
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of methylone and some of its metabolites in oral fluid 95
Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans 94
Recent challenges and trends in forensic analysis: Δ9-THC isomers pharmacology, toxicology and analysis 94
Effects of subtoxic 3-methylmethcathinone concentrations on neuronal cell electrical properties 93
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? 93
Clarifying methodological issues in cannabinoids determination in bronchoalveolar lavages 93
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers 92
Ultra-high-performance liquid chromatography tandem mass spectrometry assay for determination of endogenous ghb and ghb-glucuronide in nails 92
Synthetic cathinones related fatalities: an update 92
Cannabis: Neurological correlates in abuse and medical use 89
Medicinal cannabis and synthetic cannabinoid use 89
Pharmacological effects of methylone and MDMA in humans 89
Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs 88
A “special dose” of ethics in forensic toxicology 88
Herbal highs: Review on Psychoactive Effects and Neuropharmacology 88
Pharmacotoxicology of non-fentanyl derived new synthetic opioids 87
Segmental hair testing of triazolam to unmask a suspected case of idiopathic recurrent Stupor 85
Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices 84
The complex and constantly evolving public health threat of new psychoactive substances in Italy: Addressing the main functions of a national observatory of drugs 83
Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy 81
Metabolic pathways and potencies of new fentanyl analogs 81
Erratum to Reduced prevalence of fetal exposure to alcohol in Italy: a nationwide survey American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 6, June 2023, 100944 79
The issue of psychotropic drug monitoring in sexual assault victims 78
Global prevalence of fetal alcohol spectrum disorder in Italy 78
The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report 72
GHB concentration in breast milk of narcoleptic women treated with sodium oxybate. How important it is to be careful when interpreting values 71
Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry 70
Molecular Insights of New Psychoactive Substances (NPS) 2.0 68
Editorial: Drug-drug interactions in pharmacology 67
GHB side effects: The need to clearly document drug dose and administration history 65
Target Analysis of NPS in Oral Fluid 65
New psychoactive substances: A matter of time 63
The new synthetic benzimidazole opioid etonitazepipne: an emerging fatal harm and a challenge for laboratory medicine 61
Editorial: Analytical Advances in Clinical and Forensic Toxicology 61
Editorial: The challenge posed by new synthetic opioids: Pharmacology and toxicology 61
Molecular Insights on New Psychoactive Substances (NPSs) 58
Nails in Forensic Toxicology: an Update 55
The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances 54
Human metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations 54
Disposition of phytocannabinoids, their acidic precursors and their metabolites in biological matrices of healthy individuals treated with vaporized medical cannabis 52
GHB-facilitated sexual assaults: How to proper assess a single GHB exposure in hair 50
Totale 9.108
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.252
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 0 0 0 0 77 76 97
2021/2022436 39 58 18 7 3 41 4 29 46 34 55 102
2022/20231.093 88 124 79 75 45 308 8 59 211 3 75 18
2023/2024590 79 12 80 53 83 115 26 20 8 17 14 83
2024/20251.693 117 118 88 71 86 124 141 92 347 115 154 240
2025/20264.206 351 480 336 343 537 256 820 394 361 328 0 0
Totale 9.108